Alpha Teknova, Inc. (TKNO)
US — Healthcare Sector
Automate Your Wheel Strategy on TKNO
With Tiblio's Option Bot, you can configure your own wheel strategy including TKNO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TKNO
- Rev/Share 0.716
- Book/Share 1.4714
- PB 3.9894
- Debt/Equity 0.2081
- CurrentRatio 5.6399
- ROIC -0.2122
- MktCap 313697496.0
- FreeCF/Share -0.1325
- PFCF -44.3263
- PE -13.4626
- Debt/Assets 0.1435
- DivYield 0
- ROE -0.2848
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | TKNO | Craig Hallum | -- | Buy | -- | $12 | Feb. 10, 2025 |
News
About Alpha Teknova, Inc. (TKNO)
- IPO Date 2021-06-25
- Website https://www.teknova.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Stephen Gunstream
- Employees 173
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.